These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32198140)

  • 1. Proinflammatory S100A8 Induces PD-L1 Expression in Macrophages, Mediating Tumor Immune Escape.
    Li Z; Wang J; Zhang X; Liu P; Zhang X; Wang J; Zheng X; Wei L; Peng Q; Liu C; Yan Q; Shen S; Li X; Ma J
    J Immunol; 2020 May; 204(9):2589-2599. PubMed ID: 32198140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α.
    Hartley G; Regan D; Guth A; Dow S
    Cancer Immunol Immunother; 2017 Apr; 66(4):523-535. PubMed ID: 28184968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma.
    Zhang Y; Du W; Chen Z; Xiang C
    Exp Cell Res; 2017 Oct; 359(2):449-457. PubMed ID: 28830685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer cells promote CD169
    Jing W; Guo X; Wang G; Bi Y; Han L; Zhu Q; Qiu C; Tanaka M; Zhao Y
    Int Immunopharmacol; 2020 Jan; 78():106012. PubMed ID: 31865052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling between pancreatic β cells and macrophages via S100 calcium-binding protein A8 exacerbates β-cell apoptosis and islet inflammation.
    Inoue H; Shirakawa J; Togashi Y; Tajima K; Okuyama T; Kyohara M; Tanaka Y; Orime K; Saisho Y; Yamada T; Shibue K; Kulkarni RN; Terauchi Y
    J Biol Chem; 2018 Apr; 293(16):5934-5946. PubMed ID: 29496993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon Gamma-Induced Interferon Regulatory Factor 1 Activates Transcription of HHLA2 and Induces Immune Escape of Hepatocellular Carcinoma Cells.
    Wang R; Guo H; Tang X; Zhang T; Liu Y; Zhang C; Yu H; Li Y
    Inflammation; 2022 Feb; 45(1):308-330. PubMed ID: 34536158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.
    Jiang X; Wang J; Deng X; Xiong F; Ge J; Xiang B; Wu X; Ma J; Zhou M; Li X; Li Y; Li G; Xiong W; Guo C; Zeng Z
    Mol Cancer; 2019 Jan; 18(1):10. PubMed ID: 30646912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Juxtacrine Signaling Inhibits Antitumor Immunity by Upregulating PD-L1 Expression.
    Yang WH; Cha JH; Xia W; Lee HH; Chan LC; Wang YN; Hsu JL; Ren G; Hung MC
    Cancer Res; 2018 Jul; 78(14):3761-3768. PubMed ID: 29789418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape.
    Noguchi T; Ward JP; Gubin MM; Arthur CD; Lee SH; Hundal J; Selby MJ; Graziano RF; Mardis ER; Korman AJ; Schreiber RD
    Cancer Immunol Res; 2017 Feb; 5(2):106-117. PubMed ID: 28073774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling.
    Zong Z; Zou J; Mao R; Ma C; Li N; Wang J; Wang X; Zhou H; Zhang L; Shi Y
    Front Immunol; 2019; 10():1643. PubMed ID: 31379842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells.
    Prima V; Kaliberova LN; Kaliberov S; Curiel DT; Kusmartsev S
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1117-1122. PubMed ID: 28096371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma.
    Chen DP; Ning WR; Jiang ZZ; Peng ZP; Zhu LY; Zhuang SM; Kuang DM; Zheng L; Wu Y
    J Hepatol; 2019 Aug; 71(2):333-343. PubMed ID: 31071366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Built-in" PD-1 blocker to rescue NK-92 activity from PD-L1-mediated tumor escape mechanisms.
    Mensali N; Dillard P; Fayzullin A; Köksal H; Gaudernack G; Kvalheim G; Inderberg EM; Wälchli S
    FASEB J; 2021 Sep; 35(9):e21750. PubMed ID: 34424568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy.
    Wei Y; Zhao Q; Gao Z; Lao XM; Lin WM; Chen DP; Mu M; Huang CX; Liu ZY; Li B; Zheng L; Kuang DM
    J Clin Invest; 2019 May; 129(8):3347-3360. PubMed ID: 31112529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
    Wang QM; Lian GY; Song Y; Huang YF; Gong Y
    Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune regulation of canine tumour and macrophage PD-L1 expression.
    Hartley G; Faulhaber E; Caldwell A; Coy J; Kurihara J; Guth A; Regan D; Dow S
    Vet Comp Oncol; 2017 Jun; 15(2):534-549. PubMed ID: 26842912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer.
    Wang J; Jia Y; Zhao S; Zhang X; Wang X; Han X; Wang Y; Ma M; Shi J; Liu L
    Oncogene; 2017 Nov; 36(45):6235-6243. PubMed ID: 28714960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.
    Barsoum IB; Smallwood CA; Siemens DR; Graham CH
    Cancer Res; 2014 Feb; 74(3):665-74. PubMed ID: 24336068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance.
    Wang YH; Cao YW; Yang XC; Niu HT; Sun LJ; Wang XS; Liu J
    Asian Pac J Cancer Prev; 2014; 15(3):1321-6. PubMed ID: 24606459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.